In PCa it is involved in beta-N-acetylgalactosaminylation of prostate-specific antigen (PSA) during prostate carcinogenesis, and it is a potential marker of unfavorable prognosis in lymph node-negative locally advanced PCa [26]. The gene discussed is KLK3; the disease is prostatitis.